Jose L Mattos1, Zachary M Soler2, Rodney J Schlosser2,3, Jess C Mace4, Jeremiah A Alt5, Vijay R Ramakrishnan6, Spencer C Payne1, Timothy L Smith4, Daniel M Beswick6. 1. Division of Rhinology and Sinus Surgery, Department of Otolaryngology-Head and Neck Surgery, University of Virginia, Charlottesville, Virginia. 2. Division of Rhinology and Sinus Surgery, Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina. 3. Department of Surgery, Ralph H. Johnson VA Medical Center, Charleston, South Carolina. 4. Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, Portland, Oregon. 5. Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Utah, Salt Lake City, Utah. 6. Department of Otolaryngology, Head and Neck Surgery, University of Colorado-Anschutz Medical Campus, Aurora, Colorado.
Abstract
BACKGROUND: Many patients with chronic rhinosinusitis (CRS) have persistent olfactory dysfunction (OD) following endoscopic sinus surgery (ESS). Few studies compare outcomes to control subjects so it is unknown if residual OD is due to persistent CRS. OBJECTIVE: Compare postoperative measures of OD in case patients with CRS to healthy controls without sinonasal disease. METHODS: Prospective, observational, multicenter cohort study between October, 2016 and May, 2019. Case participants were selected from referred adult patients diagnosed with CRS, with or without nasal polyposis (NP), electing ESS as subsequent treatment modality. Controls voluntarily enrolled from a community-based sample without a history of CRS. Primary outcomes included measures of preoperative and postoperative OD using "Sniffin' Stick" pens which summarize odorant threshold (T), discrimination (D), and identification (I) scores. Secondary outcomes included the Questionnaire of Olfactory Disorders-Negative Statements (QOD-NS) survey and olfactory cleft endoscopy scores (OCES). RESULTS: Outcomes were compared between 113 cases and 164 controls of similar average age and gender. Cases reported significantly worse baseline Sniffin' Sticks TDI total scores (-6.8[SE ± 1.0]; 95% CI: -4.9 to -8.7), QOD-NS (8.9[SE ± 1.1]; 95% CI: 6.8-10.9), and OCES (3.5[SE ± 0.4]; 95% CI: 2.9-4.2) on average. Cases reported significant postoperative improvement in TDI total score (3.7[SD ± 8.2]; 95% CI: 2.2-5.2), QOD-NS (-5.9[SD ± 8.7]; 95% CI: -7.6 to -4.3), and OCES (-1.7[SD ± 3.8]; 95% CI: -2.7 to -0.8) on average, while 63% of anosmics reported improved postoperative olfaction. Multivariate regression identified that NP (OR = 0.4; 95% CI: 0.2-1.0) and previous ESS (OR = 0.3; 95% CI: 0.1-0.8) decreased the odds of postoperative improvement equal to mean TDI scores of controls, while septoplasty increased those odds (OR = 4.5; 95% CI: 1.5-13.7). CONCLUSION: ESS improved olfactory metrics and restored olfactory function in approximately 50% of patients with CRS to that of healthy controls. Concurrent septoplasty increased the likelihood of achieving normal olfaction, while NP and previous ESS decreased those odds.
BACKGROUND: Many patients with chronic rhinosinusitis (CRS) have persistent olfactory dysfunction (OD) following endoscopic sinus surgery (ESS). Few studies compare outcomes to control subjects so it is unknown if residual OD is due to persistent CRS. OBJECTIVE: Compare postoperative measures of OD in case patients with CRS to healthy controls without sinonasal disease. METHODS: Prospective, observational, multicenter cohort study between October, 2016 and May, 2019. Case participants were selected from referred adult patients diagnosed with CRS, with or without nasal polyposis (NP), electing ESS as subsequent treatment modality. Controls voluntarily enrolled from a community-based sample without a history of CRS. Primary outcomes included measures of preoperative and postoperative OD using "Sniffin' Stick" pens which summarize odorant threshold (T), discrimination (D), and identification (I) scores. Secondary outcomes included the Questionnaire of Olfactory Disorders-Negative Statements (QOD-NS) survey and olfactory cleft endoscopy scores (OCES). RESULTS: Outcomes were compared between 113 cases and 164 controls of similar average age and gender. Cases reported significantly worse baseline Sniffin' Sticks TDI total scores (-6.8[SE ± 1.0]; 95% CI: -4.9 to -8.7), QOD-NS (8.9[SE ± 1.1]; 95% CI: 6.8-10.9), and OCES (3.5[SE ± 0.4]; 95% CI: 2.9-4.2) on average. Cases reported significant postoperative improvement in TDI total score (3.7[SD ± 8.2]; 95% CI: 2.2-5.2), QOD-NS (-5.9[SD ± 8.7]; 95% CI: -7.6 to -4.3), and OCES (-1.7[SD ± 3.8]; 95% CI: -2.7 to -0.8) on average, while 63% of anosmics reported improved postoperative olfaction. Multivariate regression identified that NP (OR = 0.4; 95% CI: 0.2-1.0) and previous ESS (OR = 0.3; 95% CI: 0.1-0.8) decreased the odds of postoperative improvement equal to mean TDI scores of controls, while septoplasty increased those odds (OR = 4.5; 95% CI: 1.5-13.7). CONCLUSION: ESS improved olfactory metrics and restored olfactory function in approximately 50% of patients with CRS to that of healthy controls. Concurrent septoplasty increased the likelihood of achieving normal olfaction, while NP and previous ESS decreased those odds.
Authors: Richard R Orlandi; Todd T Kingdom; Peter H Hwang; Timothy L Smith; Jeremiah A Alt; Fuad M Baroody; Pete S Batra; Manuel Bernal-Sprekelsen; Neil Bhattacharyya; Rakesh K Chandra; Alexander Chiu; Martin J Citardi; Noam A Cohen; John DelGaudio; Martin Desrosiers; Hun-Jong Dhong; Richard Douglas; Berrylin Ferguson; Wytske J Fokkens; Christos Georgalas; Andrew Goldberg; Jan Gosepath; Daniel L Hamilos; Joseph K Han; Richard Harvey; Peter Hellings; Claire Hopkins; Roger Jankowski; Amin R Javer; Robert Kern; Stilianos Kountakis; Marek L Kowalski; Andrew Lane; Donald C Lanza; Richard Lebowitz; Heung-Man Lee; Sandra Y Lin; Valerie Lund; Amber Luong; Wolf Mann; Bradley F Marple; Kevin C McMains; Ralph Metson; Robert Naclerio; Jayakar V Nayak; Nobuyoshi Otori; James N Palmer; Sanjay R Parikh; Desiderio Passali; Anju Peters; Jay Piccirillo; David M Poetker; Alkis J Psaltis; Hassan H Ramadan; Vijay R Ramakrishnan; Herbert Riechelmann; Hwan-Jung Roh; Luke Rudmik; Raymond Sacks; Rodney J Schlosser; Brent A Senior; Raj Sindwani; James A Stankiewicz; Michael Stewart; Bruce K Tan; Elina Toskala; Richard Voegels; De Yun Wang; Erik K Weitzel; Sarah Wise; Bradford A Woodworth; Peter-John Wormald; Erin D Wright; Bing Zhou; David W Kennedy Journal: Int Forum Allergy Rhinol Date: 2016-02 Impact factor: 3.858
Authors: W J Fokkens; V J Lund; C Hopkins; P W Hellings; R Kern; S Reitsma; S Toppila-Salmi; M Bernal-Sprekelsen; J Mullol; I Alobid; W Terezinha Anselmo-Lima; C Bachert; F Baroody; C von Buchwald; A Cervin; N Cohen; J Constantinidis; L De Gabory; M Desrosiers; Z Diamant; R G Douglas; P H Gevaert; A Hafner; R J Harvey; G F Joos; L Kalogjera; A Knill; J H Kocks; B N Landis; J Limpens; S Lebeer; O Lourenco; C Meco; P M Matricardi; L O'Mahony; C M Philpott; D Ryan; R Schlosser; B Senior; T L Smith; T Teeling; P V Tomazic; D Y Wang; D Wang; L Zhang; A M Agius; C Ahlstrom-Emanuelsson; R Alabri; S Albu; S Alhabash; A Aleksic; M Aloulah; M Al-Qudah; S Alsaleh; M A Baban; T Baudoin; T Balvers; P Battaglia; J D Bedoya; A Beule; K M Bofares; I Braverman; E Brozek-Madry; B Richard; C Callejas; S Carrie; L Caulley; D Chussi; E de Corso; A Coste; U El Hadi; A Elfarouk; P H Eloy; S Farrokhi; G Felisati; M D Ferrari; R Fishchuk; W Grayson; P M Goncalves; B Grdinic; V Grgic; A W Hamizan; J V Heinichen; S Husain; T I Ping; J Ivaska; F Jakimovska; L Jovancevic; E Kakande; R Kamel; S Karpischenko; H H Kariyawasam; H Kawauchi; A Kjeldsen; L Klimek; A Krzeski; G Kopacheva Barsova; S W Kim; D Lal; J J Letort; A Lopatin; A Mahdjoubi; A Mesbahi; J Netkovski; D Nyenbue Tshipukane; A Obando-Valverde; M Okano; M Onerci; Y K Ong; R Orlandi; N Otori; K Ouennoughy; M Ozkan; A Peric; J Plzak; E Prokopakis; N Prepageran; A Psaltis; B Pugin; M Raftopulos; P Rombaux; H Riechelmann; S Sahtout; C-C Sarafoleanu; K Searyoh; C-S Rhee; J Shi; M Shkoukani; A K Shukuryan; M Sicak; D Smyth; K Sindvongs; T Soklic Kosak; P Stjarne; B Sutikno; S Steinsvag; P Tantilipikorn; S Thanaviratananich; T Tran; J Urbancic; A Valiulius; C Vasquez de Aparicio; D Vicheva; P M Virkkula; G Vicente; R Voegels; M M Wagenmann; R S Wardani; A Welge-Lussen; I Witterick; E Wright; D Zabolotniy; B Zsolt; C P Zwetsloot Journal: Rhinology Date: 2020-02-20 Impact factor: 3.681
Authors: Richard M Rosenfeld; Jay F Piccirillo; Sujana S Chandrasekhar; Itzhak Brook; Kaparaboyna Ashok Kumar; Maggie Kramper; Richard R Orlandi; James N Palmer; Zara M Patel; Anju Peters; Sandra A Walsh; Maureen D Corrigan Journal: Otolaryngol Head Neck Surg Date: 2015-04 Impact factor: 3.497
Authors: Rodney J Schlosser; Timothy L Smith; Jess C Mace; Jeremiah Alt; Daniel M Beswick; Jose L Mattos; Spencer Payne; Vijay R Ramakrishnan; Zachary M Soler Journal: Int Forum Allergy Rhinol Date: 2020-01 Impact factor: 3.858